Pine Labs IPO: Valuation, Margins and Paytm Check

Why Pine Labs is trending on investor forums

Pine Labs is being discussed heavily because it is positioning itself as a full-stack merchant commerce and payments platform. Social posts describe its core as PoS solutions, payment processing, and merchant financing. The IPO also lands at a time when investors are scrutinising valuation more than narratives, according to the discussions. Several comparisons are being made with One 97 Communications (Paytm) and other listed peers like Zaggle. A key point of debate is whether fintech valuations are justified in a competitive, UPI-led market. Another recurring theme is the trade-off between operating efficiency and a premium valuation based on future growth. Posts also flag that expectations for listing gains look muted based on grey market chatter. Overall, the tone is cautious but curious, with many calling it a long-horizon decision.

IPO structure, dates, and price band being tracked

The price band being cited is ₹210 to ₹221 per share. The IPO window referenced in the discussions is November 7 to November 11, 2025. The offer is described as a mix of a fresh issue and an offer for sale (OFS). The fresh issue size quoted is ₹2,080 crore. The OFS is described as over 8.23 crore equity shares, estimated at about ₹1,819.9 crore at the upper end of the band. Multiple posts also summarise the total issue size around ₹3,899.91 crore, often rounded to near-₹4,000 crore. Separately, some social posts mention a different fundraising figure and valuation framing from an earlier DRHP discussion, so readers are treating numbers with care. The subscription commentary in the feed says the issue was well-received and crossed 50% subscription at the time of those posts.

Business model recap: merchant-first rather than consumer-first

The most consistent description across posts is that Pine Labs is merchant-focused. It helps businesses accept digital payments and also enables credit options at the point of sale. In the Hindi commentary shared, Pine Labs is repeatedly framed as a PoS and merchant commerce player that you encounter at retail counters. Competitive references include Paytm, Razorpay, and BharatPe in India. Investors are also discussing its ambitions outside India, with execution risk highlighted for international expansion. Some posts attribute higher costs to scaling devices and expanding the product stack. Others argue that a merchant platform can build recurring service revenue if the SaaS layer is sticky. The bull case in the thread is built around the company being technologically strong and diversified across merchant use cases. The bear case focuses on whether payments pricing and competition can compress the take-rate over time.

Revenue scale: Pine Labs versus Paytm (as shared)

A simple reason Paytm keeps coming up is scale, because its reported operating revenue is much larger in the shared table. The same table also shows Pine Labs growing across FY23 to FY25 and into Q1 FY26. Social posts highlight that Pine Labs remains smaller, which affects how investors interpret valuation multiples. Here is the revenue table that circulated in the threads.

The key takeaway investors are making is that Pine Labs is not being priced like a tiny niche player. Instead, discussions frame it as being valued like a scaled platform that can keep compounding. That is why posters repeatedly compare the offer to Paytm’s public market valuation and multiples. A few comments also mention that some investors are benchmarking to revenue multiples rather than near-term profits. The table is also used to argue that momentum in quarterly revenue matters for sentiment.

Profitability focus: margins, adjusted EBITDA, and losses

A Mint-cited excerpt in the discussion says Pine Labs had an operating margin of 19.6% in Q1 FY26. That figure is being used to argue Pine Labs shows stronger profitability than certain listed rivals in the same period. Another peer-comparison table circulated with adjusted EBITDA margins and profit figures for Pine Labs, Paytm, and Zaggle. Investors are using it to separate margin profile from revenue scale. It also highlights that Pine Labs and Paytm were loss-making on the profit line in that snapshot, while Zaggle showed positive profit. Separately, a social post claims FY24 revenue and losses for Pine Labs and flags that losses increased versus the prior year, which is driving scepticism. Because the thread mixes sources, most due diligence comments focus on what is consistent: margin improvement is central to the bull thesis. At the same time, posters warn that operating leverage needs to appear faster if competition keeps fees low.

Valuation debate: EV, EV/Sales, and EV/EBITDA comparisons

The most repeated valuation anchor is the enterprise value being sought, cited as ₹18,093 crore. Posts compare that with Paytm’s enterprise value cited at ₹69,965 crore, Zaggle at ₹4,349 crore, and One Mobikwik Systems at ₹1,380 crore. The SBICAP Securities note referenced in the discussion says that at the upper band, Pine Labs is valued at EV/Sales of 8.0x, EV/EBITDA of 82.8x, and EV/Adj EBITDA of 50.7x on a post-issue basis. The same comparison list shows Paytm at EV/Sales of 10.1x and EV/EBITDA of (46.4)x. Investors interpret the negative EV/EBITDA as reflecting losses, which complicates straight comparisons. Another excerpt says Pine Labs is valued at roughly 11 times FY25 operating revenue, comparable to Paytm’s 11.8x but above Zaggle’s 3.7x, as per Mint’s analysis. The recurring pushback is that 8x EV/Sales and 82.8x EV/EBITDA imply high expectations for future growth. Supporters counter that improving margins and merchant platform depth can justify a premium if execution continues.

Grey market premium and the listing-gains conversation

A widely shared GMP number in the thread is around ₹12. That is described as implying roughly a 5.43% gain over the issue price. Several posts therefore frame the IPO as not being designed for quick listing pop expectations. Instead, commentators label it a long-term play if one believes in margin expansion and international execution. Some posters explicitly say investors should not expect significant listing gains given the modest GMP. Others caution that GMP is not a fundamental metric and can move quickly with sentiment. Still, the GMP chatter is influencing how retail investors are thinking about allocation. The dominant narrative is that the offer will be judged on post-listing earnings trajectory rather than day-one demand alone. This ties back to the repeated message that investors are now sifting harder through numbers than narratives.

Due diligence checklist investors are using in comments

The most common due diligence question is about take-rate and sustainability in a UPI-led ecosystem, as mentioned in the social posts. Another recurring check is whether the SaaS layer is sticky enough to support recurring income beyond payments processing. Investors are also looking at operating leverage, because hardware rollout and device procurement can keep costs elevated. Competitive intensity is a constant theme, with Paytm, Razorpay, and BharatPe cited repeatedly. The offer structure is also being read as a signal, because it includes a fresh issue for business needs and an OFS that enables partial exits for existing stakeholders. Posts list potential use of proceeds such as debt repayment, subsidiary investments, technology development (cloud and AI/ML), device procurement, strategic acquisitions, and general corporate purposes. A practical investor angle is to reconcile the different valuation narratives seen across posts, including references to prior private valuations and later mark-down framing. Finally, many commenters conclude that the decision hinges on comfort with premium valuation multiples and confidence that margin improvement continues while the market remains competitive.